Literature DB >> 11039516

Synchronous ovarian and endometrial malignancies.

I M Castro1, P P Connell, S Waggoner, J Rotmensch, A J Mundt.   

Abstract

Synchronous ovarian primaries are infrequently found in patients with endometrial cancer. Although numerous investigators have examined the characteristics of these women, most include patients with tumors of similar histology, which may simply represent ovarian metastases. To overcome this problem, we present here patients found to have tumors of dissimilar histology. Of 499 patients with endometrial cancer undergoing primary surgery between 1980 and 1997, 18 (3.6%) were found to have endometrial and ovarian primaries of dissimilar histology. The median age was 64.2 years. Most had stage I, grades I and II, minimally invasive endometrial adenocarcinomas and stage IA mucinous or serous ovarian cystadenocarcinomas. Most ovarian tumors were either borderline or grades I and II. The 5-year actuarial disease-free (DFS) and cause-specific survivals of the entire group were 81.2% and 89.5%, respectively. Those with both stage I ovarian and endometrial primaries had a trend to a better DFS (100 versus 68.6%, p = 0.07) than did women with higher stage disease. Our data demonstrate that synchronous ovarian primaries of dissimilar histology are infrequently found in women undergoing surgery for endometrial cancer. These women seek treatment at a relatively advanced age, and have early-stage, low grade disease in both sites. Their outcome is favorable, particularly those with stage I disease in both sites.

Entities:  

Mesh:

Year:  2000        PMID: 11039516     DOI: 10.1097/00000421-200010000-00018

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

1.  Hydrosalpinx as a Rare Presentation of Synchronous Ovarian and Endometrial Carcinoma - A Case Report.

Authors:  Mahjabeen Khan; Sapna Vinit Amin; Sujatha Bagepalli Srinivas; Roopa Padavagodu Shivananda; Navin Patil
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 2.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

3.  Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.

Authors:  M M AlHilli; S C Dowdy; A L Weaver; J L St Sauver; G L Keeney; A Mariani; K C Podratz; J N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2011-12-28       Impact factor: 5.482

4.  Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.

Authors:  Lu Chen; Qiang Zhao; Xiaojuan Lv
Journal:  Arch Gynecol Obstet       Date:  2010-06-29       Impact factor: 2.344

5.  Synchronous Endometrial and Ovarian Carcinoma: A Case Series.

Authors:  Georgios-Marios Makris; Georgia Manousopoulou; Marco-Johannes Battista; Ioannis Salloum; Georgios Chrelias; Charalampos Chrelias
Journal:  Case Rep Oncol       Date:  2017-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.